Novo Nordisk sues Hims for GLP-1 patent infringement

Imitation is the sincerest form of flattery, some say. Novo Nordisk would probably disagree. Copycats of the company’s popular weight loss treatment, Wegovy, have been popping up for years. One copycat comes from the company Hims & Hers, an online provider of obesity medications as well as erectile dysfunction and hair regrowth treatments.  Hims &… The post Novo Nordisk sues Hims for GLP-1 patent infringement appeared first on Drug Discovery and Development.

Continue reading →